Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

261

HTML

2516

Figures (1-3)

249

Tables (1-1)

239

Sum=3265

Jun 7, 2005 (publication date) through Feb 1, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 7, 2005; 11(21): 3222-3226
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3222

Full Size Figure Download Figure

Figure 3 No significant differences between positive cases and negative cases in Kaplan–Meier survival analysis of MMP-2 mRNA.

Citation: Ji F, Chen YL, Jin EY, Wang WL, Yang ZL, Li YM. Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer. World J Gastroenterol 2005; 11(21): 3222-3226
URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3222.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3222